Supplemental material
Open access
3,965
Views
15
CrossRef citations to date
0
Altmetric
Research Paper
Identification of novel CDK2 inhibitors by a multistage virtual screening method based on SVM, pharmacophore and docking model
Jing-Wei LiangSchool of Pharmacy, China Medical University, Shen Yang, ChinaView further author information
, Ming-Yang WangSchool of Pharmacy, China Medical University, Shen Yang, ChinaView further author information
, Shan WangSchool of Pharmacy, China Medical University, Shen Yang, ChinaView further author information
, Shi-Long LiSchool of Pharmacy, China Medical University, Shen Yang, ChinaView further author information
, Wan-Qiu LiSchool of Pharmacy, China Medical University, Shen Yang, ChinaView further author information
& Fan-Hao MengSchool of Pharmacy, China Medical University, Shen Yang, ChinaCorrespondence[email protected]
View further author information
View further author information
Pages 235-244
|
Received 06 Aug 2019, Accepted 10 Nov 2019, Published online: 25 Nov 2019
Related Research Data
Cyclin-dependent kinase-2 as a target for cancer therapy: progress in the development of CDK2 inhibitors as anti-cancer agents.
Source:
Bentham Science Publishers Ltd.
Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor.
Source:
Springer Science and Business Media LLC
Improved protein-ligand docking using GOLD.
Source:
Wiley
Extended-Connectivity Fingerprints
Source:
American Chemical Society (ACS)
Discovery of Novel Pim-1 Kinase Inhibitors by a Hierarchical Multistage Virtual Screening Approach Based on SVM Model, Pharmacophore, and Molecular Docking
Source:
American Chemical Society (ACS)
Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loop.
Source:
Elsevier BV
Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations.
Source:
American Chemical Society (ACS)
Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking
Source:
American Chemical Society (ACS)
Identification of novel CDK2 inhibitors by a multistage virtual screening method based on SVM, pharmacophore and docking model
Source:
Figshare
A review about the development of fucoidan in antitumor activity: Progress and challenges.
Source:
Elsevier BV
Binding energy landscape analysis helps to discriminate true hits from high-scoring decoys in virtual screening.
Source:
American Chemical Society (ACS)
Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
Source:
Frontiers Media SA
A library for support vector machines
Source:
Association for Computing Machinery (ACM)
Scalable molecular dynamics with NAMD
Source:
Wiley
Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
Source:
Elsevier BV
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.